The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Gene therapy with helper-dependent adenoviral vectors: lessons from studies in large animal models
Abstract
Helper-dependent adenoviral vectors (HDAd) are deleted of all viral genes and they can efficiently transduce a wide variety of dividing and non-dividing cells to mediate high transgene expression levels. Unlike early generation adenoviral vectors, the absence of viral genes in HDAd results in long-term transgene expression without chronic toxicity and permits a large cloning capacity of 36 kb. Moreover, HDAd genomes exist extra-chromosomally thus minimizing the risks of germline transmission and insertional mutagenesis. For these reasons, HDAd offers tremendous potential for in vivo gene therapy. This chapter reviews preclinical studies using HDAd in large animal models to assess safety and efficacy in a wide variety of gene therapy applications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Maximum serum concentration of genes in gene augmentation therapy gradually decline to about 10% in 24 months due to acute phase immune responses and neutralizing antibodies, thus hampering the efficacy of gene augmentation therapy [34].”
From Viral Delivery Systems for CRISPR (2019) · cites this paper as [34]
Citations
Cites
Morral, N., O’Neal, W., Rice, K., Leland, M., Kaplan, J., Piedra, P. A., Zhou, H., Parks, R. J., Velji, R., Aguilar-Córdova, E., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12816 · Cited by 409
Stanley, D. A., Honko, A. N., Asiedu, C., Trefry, J. C., Lau-Kilby, A. W., Johnson, J. C., Hensley, L., Ammendola, V., Abbate, A., Grazioli, F., et al. (2014) · Nature Medicine · doi:10.1038/nm.3702 · Cited by 350
Brunetti-Pierri, N., Palmer, D. J., Beaudet, A. L., Carey, K. D., Finegold, M., & Ng, P. (2004) · Human Gene Therapy · doi:10.1089/10430340460732445 · Cited by 256
Self-citationMok, H., Palmer, D. J., Ng, P., & Barry, M. A. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.09.015 · Cited by 232
Self-citationLiver transplantation for glycogen storage disease types I, III, and IV
Matern, D., Starzl, T. E., Arnaout, W., Barnard, J., Bynon, J. S., Dhawan, A., Emond, J., Haagsma, E. B., Hug, G., Lachaux, A., et al. (1999) · European Journal of Pediatrics · doi:10.1007/pl00014320 · Cited by 185
Chuah, M., Schiedner, G., Thorrez, L., Brown, B. D., Johnston, M., Gillijns, V., Hertel, S., van Rooijen, N., Lillicrap, D., Collen, D., et al. (2003) · Blood · doi:10.1182/blood-2002-03-0823 · Cited by 147
Croyle, M. A., Le, H. T., Linse, K. D., Cerullo, V., Toietta, G., Beaudet, A. L., & Pastore, L. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302441 · Cited by 125
Episomal Persistence of Recombinant Adenoviral Vector Genomes during the Cell Cycle In Vivo
Ehrhardt, A., Xu, H., & Kay, M. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.13.7689-7695.2003 · Cited by 108
Hofherr, S. E., Shashkova, E. V., Weaver, E. A., Khare, R., & Barry, M. A. (2008) · Molecular Therapy · doi:10.1038/mt.2008.86 · Cited by 95
Brunetti‐Pierri, N., Stapleton, G. E., Law, M. A., Breinholt, J. P., Palmer, D. J., Zuo, Y., Grove, N. C., Finegold, M. J., Rice, K., Beaudet, A. L., et al. (2008) · Molecular Therapy · doi:10.1038/mt.2008.257 · Cited by 89
Self-citationBrunetti‐Pierri, N., Ng, T., Iannitti, D. A., et al. (2013) · Human Gene Therapy · doi:10.1089/hum.2013.071 · Cited by 88
Self-citationBrown, B. D., Chang, S., Powell, S., Hurlbut, D. J., Graham, F. L., & Lillicrap, D. (2003) · Blood · doi:10.1182/blood-2003-05-1426 · Cited by 88
Identification of Adenovirus Serotype 5 Hexon Regions That Interact with Scavenger Receptors
Khare, R., Reddy, V. S., Nemerow, G. R., & Barry, M. A. (2011) · Journal of Virology · doi:10.1128/jvi.05760-11 · Cited by 88
Mück-Häusl, M., Zhang, W., Müther, N., Rauschhuber, C., Franck, H. W. G., Merricks, E. P., Nichols, T. C., Kay, M. A., & Ehrhardt, A. (2010) · Molecular Therapy · doi:10.1038/mt.2010.169 · Cited by 85
Prill, J.-M., Espenlaub, S., Samen, U., Engler, T., Schmidt, E., Vetrini, F., Rosewell, A., Grove, N. C., Palmer, D. J., Ng, P., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.229 · Cited by 80
Self-citationBrunetti‐Pierri, N., Nichols, T. C., McCorquodale, S., Merricks, E. P., Palmer, D. J., Beaudet, A. L., & Ng, P. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.811 · Cited by 80
Self-citationBrunetti‐Pierri, N., Stapleton, G. E., Palmer, D. J., Zuo, Y., Mane, V. P., Finegold, M. J., Beaudet, A. L., Leland, M. M., Mullins, C. E., & Ng, P. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300102 · Cited by 78
Self-citationEhrhardt, A., Xu, H., Dillow, A. M., Bellinger, D. A., Nichols, T. C., & Kay, M. A. (2003) · Blood · doi:10.1182/blood-2003-01-0314 · Cited by 77
Liver transplantation for glycogen storage disease type Ia
Reddy, S. K., Austin, S. L., Spencer‐Manzon, M., Koeberl, D. D., Clary, B. M., Desai, D. M., Smith, A. D., & Kishnani, P. S. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.05.026 · Cited by 76
Brunetti‐Pierri, N., Ng, T., Iannitti, D. A., Palmer, D. J., Beaudet, A. L., Finegold, M. J., Carey, K. D., Cioffi, W. G., & Ng, P. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.391 · Cited by 73
Self-citationComparison of Replication-Competent, First Generation, and Helper-Dependent Adenoviral Vaccines
Weaver, E. A., Nehete, P. N., Buchl, S. J., Senac, J. S., Palmer, D. J., Ng, P., Sastry, K. J., & Barry, M. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005059 · Cited by 73
Self-citationKoehler, D. R., Frndova, H., Leung, K., Louca, E., Palmer, D. J., Ng, P., McKerlie, C., Cox, P. G. F., Coates, A. L., & Hu, J. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.797 · Cited by 70
Self-citationBrunetti‐Pierri, N., Palmer, D. J., Mane, V. P., Finegold, M. J., Beaudet, A. L., & Ng, P. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.03.001 · Cited by 67
Self-citationMcCORMACK, W. M., Seiler, M. P., Bertin, T., UBHAYAKAR, K., Palmer, D. J., Ng, P., Nichols, T. C., & Lee, B. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01901.x · Cited by 67
Self-citationJäger, L., & Ehrhardt, A. (2009) · Human Gene Therapy · doi:10.1089/hum.2009.020 · Cited by 50
Ross, P. J., Kennedy, M. A., & Parks, R. J. (2009) · Journal of Virology · doi:10.1128/jvi.00796-09 · Cited by 50
Assembly of Helper-Dependent Adenovirus DNA into Chromatin Promotes Efficient Gene Expression
Ross, P. J., Kennedy, M. A., Christou, C., Quiroz, M. R., Poulin, K. L., & Parks, R. J. (2011) · Journal of Virology · doi:10.1128/jvi.01787-10 · Cited by 49
Cao, H., Machuca, T., Yeung, J. C., Wu, J., Du, K., Duan, C., Hashimoto, K., S, V. L., Coates, A. L., Leung, K., et al. (2013) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.55 · Cited by 45
Brunetti‐Pierri, N., Liou, A., Patel, P., Palmer, D. J., Grove, N. C., Finegold, M. J., Piccolo, P., Donnachie, E., Rice, K., Beaudet, A. L., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2012.143 · Cited by 42
Self-citationSpecies Differences in the Pharmacology and Toxicology of PEGylated Helper-Dependent Adenovirus
Wonganan, P., Clemens, C. C., Brasky, K., Pastore, L., & Croyle, M. A. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100216h · Cited by 38
Crettaz, J. S., Otano, I., Ochoa‐Callejero, L., Benito, A., Pañeda, A., Aurrekoetxea, I., Berraondo, P., Rodríguez-Madoz, J. R., Astudillo, A., Kreppel, F., et al. (2011) · Journal of Virology · doi:10.1128/jvi.06454-11 · Cited by 38
Crettaz, J. S., Otano, I., Ochoa‐Callejero, L., Benito, A., Pañeda, A., Aurrekoetxea, I., Berraondo, P., Rodríguez-Madoz, J. R., Astudillo, A., Kreppel, F., et al. (2008) · Journal of Virology · doi:10.1128/jvi.02384-08 · Cited by 34
Protection against Mucosal SHIV Challenge by Peptide and Helper-Dependent Adenovirus Vaccines
Weaver, E. A., Nehete, P. N., Nehete, B. P., Buchl, S. J., Palmer, D. J., Montefiori, D. C., Ng, P., Sastry, K. J., & Barry, M. A. (2009) · Viruses · doi:10.3390/v1030920 · Cited by 29
Self-citationCrane, B., Luo, X., DeMaster, A. K., Williams, K. D., Kozink, D. M., Zhang, P., Brown, T. T., Pinto, C. R. F., Oka, K., Sun, F., et al. (2011) · Gene Therapy · doi:10.1038/gt.2011.86 · Cited by 29
Leggiero, E., Astone, D., Cerullo, V., Lombardo, B., Mazzaccara, C., Labruna, G., Sacchetti, L., Salvatore, F., Croyle, M. A., & Pastore, L. (2013) · Gene Therapy · doi:10.1038/gt.2013.38 · Cited by 28
Fiedler, M., Kosinska, A. D., Schumann, A., Brovko, O., Walker, A., Lu, M., Johrden, L., Mayer, A., Wildner, O., & Roggendorf, M. (2013) · Journal of Virology · doi:10.1128/jvi.00645-13 · Cited by 27
Rastall, D. P. W., Seregin, S. S., Aldhamen, Y. A., Kaiser, L., Mullins, C. E., Liou, A., Ing, F. F., Pereria-Hicks, C., Godbehere, S., Palmer, D. J., et al. (2016) · Gene Therapy · doi:10.1038/gt.2016.53 · Cited by 24
Self-citationOka, K., Mullins, C. E., Kushwaha, R. S., Leen, A. M., & Chan, L. (2014) · Gene Therapy · doi:10.1038/gt.2014.85 · Cited by 21
Otano, I., Suárez-Amarán, L., Dotor, J., González-Aparicio, M., Crettaz, J. S., Olagüe, C., Vales, Á., Riezu‐Boj, J. I., Larrea, E., Borrás, F., et al. (2012) · Hepatology · doi:10.1002/hep.25667 · Cited by 21
The Role of Chromatin in Adenoviral Vector Function
Wong, C., McFall, E. R., Burns, J. K., & Parks, R. J. (2013) · Viruses · doi:10.3390/v5061500 · Cited by 20
Challenges and Prospects for Helper-Dependent Adenoviral Vector-Mediated Gene Therapy
Piccolo, P., & Brunetti‐Pierri, N. (2014) · Biomedicines · doi:10.3390/biomedicines2020132 · Cited by 18
Self-citationUnzu, C., Melero, I., Hervás‐Stubbs, S., Sampedro, A., Mancheño, U., Morales‐Kastresana, A., Serrano-Mendioroz, I., de Salamanca, R. E., Benito, A., & Fontanellas, A. (2015) · Gene Therapy · doi:10.1038/gt.2015.64 · Cited by 16
Helper-dependent Adenoviral Vectors for Gene Therapy
Ng, P., & Graham, F. L. (2000) · Gene Therapy · doi:10.1201/9781420002126-11 · Cited by 9
Self-citationHelper-Dependent Adenoviral Vectors for Gene Therapy
Brunetti‐Pierri, N., & Ng, P. (2015) · CRC Press eBooks · doi:10.1201/b18002-5 · Cited by 2
Self-citation
Cited by
Gene Therapy Leaves a Vicious Cycle
Goswami, R., Subramanian, G., Silayeva, L., Newkirk, I., Doctor, D., Chawla, K., Chattopadhyay, S., Chandra, D., Chilukuri, N., & Betapudi, V. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00297 · Cited by 347
Viral Delivery Systems for CRISPR
Xu, C. L., Ruan, M. Z. C., Mahajan, V. B., & Tsang, S. H. (2019) · Viruses · doi:10.3390/v11010028 · Cited by 277
“Maximum serum concentration of genes in gene augmentation therapy gradually decline to about 10% in 24 months due to acute phase immune responses and neutralizing antibodies, thus hampering the efficacy of gene augmentation therapy [34].”
BackgroundViral Vectors for Gene Transfer
Chen, Y. H., Keiser, M. S., & Davidson, B. L. (2018) · Current Protocols in Mouse Biology · doi:10.1002/cpmo.58 · Cited by 146
Metadata
- Authors
- Brunetti-Pierri, N., & Ng, P.
- Venue
- Virus Genes
- Published
- 2017-06-07
- Volume
- 53
- Issue
- 5
- Pages
- 684-691
- ISSN
- 0920-8569
- 1572-994X
- Cited by
- 32
- References
- 44
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.